These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Updates and Recent Advances on Venom Immunotherapy. Floyd ML; Adams KE; Golden DBK Curr Treat Options Allergy; 2023 Apr; ():1-19. PubMed ID: 37361640 [TBL] [Abstract][Full Text] [Related]
4. Advances in allergen immunotherapy in 2015. Bush RK J Allergy Clin Immunol; 2016 Nov; 138(5):1284-1291. PubMed ID: 27817799 [TBL] [Abstract][Full Text] [Related]
5. [Advances in Immunotherapy for Malignant Pleural Mesothelioma]. Chi Y; Liu Y; Zhao J Zhongguo Fei Ai Za Zhi; 2022 Apr; 25(4):259-265. PubMed ID: 35477190 [TBL] [Abstract][Full Text] [Related]
6. Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer. Liu X; Li Z; Wang Y Adv Biol (Weinh); 2021 Mar; 5(3):e1900236. PubMed ID: 33729700 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in hematological malignancies: recent advances and open questions. Tawfik EA; Aldrak NA; Albrahim SH; Alzahrani DA; Alfassam HA; Alkoblan SM; Almalik AM; Chen KS; Abou-Khalil R; Shah K; Zaidan NM Immunotherapy; 2021 Oct; 13(14):1215-1229. PubMed ID: 34498496 [TBL] [Abstract][Full Text] [Related]
8. The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practices. Cheng H; Zhou D; Wang S; Ding J; Ma F Biosci Trends; 2021 Mar; 15(1):9-15. PubMed ID: 33551416 [TBL] [Abstract][Full Text] [Related]
9. Advances in targeted therapy and immunotherapy for esophageal cancer. Yang H; Li X; Yang W Chin Med J (Engl); 2023 Aug; 136(16):1910-1922. PubMed ID: 37403208 [TBL] [Abstract][Full Text] [Related]
10. Top advances of the year: Breast cancer. Saavedra C; Gion M; Cortés J; Llombart-Cussac A Cancer; 2023 Jun; 129(12):1791-1794. PubMed ID: 37014257 [TBL] [Abstract][Full Text] [Related]
11. Translating Science into Survival: Report on the Fourth International Cancer Immunotherapy Conference. Diken M; Ravoori S; Brodsky AN Cancer Immunol Res; 2019 Jan; 7(1):2-5. PubMed ID: 30602506 [TBL] [Abstract][Full Text] [Related]
12. Advances in tumour immunotherapy. King J; Waxman J; Stauss H QJM; 2008 Sep; 101(9):675-83. PubMed ID: 18477644 [TBL] [Abstract][Full Text] [Related]
14. [Advances of immunotherapy-related biomarker in esophageal carcinoma]. Zhang RX; Kang XZ; Zheng QF; Wang Z; Chen XK; Li Y; Qin JJ; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):396-400. PubMed ID: 37072320 [TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. Smith C; Zheng W; Dong J; Wang Y; Lai J; Liu X; Yin F World J Gastroenterol; 2022 Jul; 28(27):3297-3313. PubMed ID: 36158269 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in T-cell immunotherapy for haematological malignancies. Rouce RH; Sharma S; Huynh M; Heslop HE Br J Haematol; 2017 Mar; 176(5):688-704. PubMed ID: 27897332 [TBL] [Abstract][Full Text] [Related]
17. Advances in immunotherapy for pancreatic cancer: 2013. DeVito NC; Saif MW JOP; 2013 Jul; 14(4):347-53. PubMed ID: 23846925 [TBL] [Abstract][Full Text] [Related]
18. [Recent advances and future challenges in cancer immunotherapy]. Okuyama N; Tamada K; Tamura H Rinsho Ketsueki; 2016; 57(11):2388-2395. PubMed ID: 27941290 [TBL] [Abstract][Full Text] [Related]
19. Pioneering the trail of cancer immunotherapy. Kotlan B; Balwit JM Expert Rev Anticancer Ther; 2011 Mar; 11(3):351-4. PubMed ID: 21417850 [TBL] [Abstract][Full Text] [Related]
20. An Update on the Use of Immunotherapy in the Treatment of Lymphoma. Marron TU; Kalac M; Brody J Curr Hematol Malig Rep; 2017 Aug; 12(4):282-289. PubMed ID: 28735365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]